Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

doi:10.3748/wjg.v22.i47.10275

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12105)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

873

WORD

352

HTML

6650

Figures (1-3)

249

Tables (1-3)

165

Sum=8289

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

588

Download

624

Sum=1212

Publishing Process of This Article

Item

Count

Browse

1159

Download

1445

Sum=2604

Dec 21, 2016 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 21, 2016; 22(47): 10275-10286
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10275

Table 3 Serine protease inhibitors investigated in experimental visceral hypersensitivity models

Inhibitor name	Target(s)	Ref.
Aprotinin	Chymotrypsin, elastase, KLK, plasmin, PA, trypsin, urokinase, XIIa	[49]
Bowman-Birk inhibitor	Chymotrypsin, trypsin	[70,71]
Camostat mesilate (FOY-305)	Trypsin, matriptase, prostasin, plasmin, tPA, uPA, Xa, IXa, thrombin, tissue factor, complement factors, tryptase, HNE, KLK	[68,69]
Cathepsin-G inhibitor	Cathepsin G	[49]
Nafamostat mesilate (FUT-175)	Tryptase, trypsin, C1r, C1s, thrombin, kallikrein, plasmin	[37,65-67]
UAMC-0050	Tryptase, matriptase, KLK4, KLK8, uPA	[66,67,93]
Soybean trypsin inhibitor (SBTI)	Trypsin, chymotrypsin, plasmin, kallikrein, Xa	[49]

C1r: Complement component 1r; C1s: Complement component 1s; HNE: 4-hydoxynonenal; KLK: Kallikrein; PA: Plasminogen activator; tPA: Tissue plasminogen activator; uPA: Urokinase plasminogen activator.

Citation: Ceuleers H, Van Spaendonk H, Hanning N, Heirbaut J, Lambeir AM, Joossens J, Augustyns K, De Man JG, De Meester I, De Winter BY. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J Gastroenterol 2016; 22(47): 10275-10286
URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10275.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i47.10275